Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Management to Present at May Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--April 27, 2004--Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Management will present at three conferences in May 2004.

On Tuesday, May 4th, at 11:25 a.m. CDT, Chairman, President and Chief Executive Officer James C. Foster will present at the Baird 2004 Growth Stock Conference in Chicago.

On Wednesday, May 19th, at 10:40 a.m. PDT, Chief Financial Officer Thomas F. Ackerman will present at the Bank of America Securities Global Equities Health Care Conference in Las Vegas.

On Wednesday, May 26th at 11:00 a.m. EDT, James C. Foster will present at the Credit Suisse First Boston Small Cap Growth Conference in New York.

A live webcast of each presentation will be available through links that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay for each conference will be accessible through the same website approximately three hours after the presentation and will remain available for one week from the date of the presentation.


    CONTACT: Charles River Laboratories International, Inc.
             Investor Relations:
             Susan E. Hardy, 978-658-6000 Ext.1616

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)